You just read:

Positive Phase III Results for Two Antibiotics, Zinforo™▼ and Investigational Ceftazidime-Avibactam, Presented at Leading Infectious Diseases Conference

News provided by

AstraZeneca

27 Apr, 2015, 08:00 BST